Company News Summary
ResMed Announces Record Financial Results for the Six Months Ended 21 December 2012
Original announcement: Record Financial Results for Q/E & 6 Months Dec 31, 2012
ResMed announced record revenue and income for the quarter ended 31 December 2012. Revenue for the quarter was $376.5m, a 13% increase (a 14% increase on a constant currency basis) over the quarter ended 31 December 2011. Net income was $77.9m, an increase of 24% compared to the quarter ended 31 December 2011. Diluted EPS for the quarter were $0.53, an increase of 26% compared to the previous corresponding quarter. For the six months ended 31 December 2012, revenue was $716.3m, an increase of 11% over the six months ended 31 December 2011 (a 13% increase on a constant currency basis). Net income for the six months was $149.2m, an increase of 32% compared to the pcp. Diluted EPS for the six months were $1.02 per diluted share, an increase of 36% compared to the pcp.
See more ASX300 News Announcements